Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Dwyer

Showing results (341-350 of 359) with videos related to

Pageof 36
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 1, 2026
Impact of multiple sclerosis disease-modifying therapies on chronic lesion tissue expansionDaniel Guilfoyle, Kayla Ward, Samuel Klistorner, et al.
Therapeutic Advances in Neurological Disorders|December 25, 2010
A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosisElliot M Frohman, Gary Cutter, Gina Remington, et al.
Neuroimage. Clinical|May 8, 2024
Thalamic atrophy and dysconnectivity are associated with cognitive impairment in a multi-center, clinical routine, real-word study of people with relapsing-remitting multiple sclerosisRobert Zivadinov, Niels Bergsland, Dejan Jakimovski, et al.
Science (New York, N.Y.)|June 8, 2013
Space partitioning without territoriality in gannetsEwan D Wakefield, Thomas W Bodey, Stuart Bearhop, et al.
Brain : a Journal of Neurology|March 23, 2021
Deep grey matter injury in multiple sclerosis: a NAIMS consensus statementDaniel Ontaneda, Praneeta C Raza, Kedar R Mahajan, et al.
Biological Conservation|September 28, 2021
The power of national acoustic tracking networks to assess the impacts of human activity on marine organisms during the COVID-19 pandemicCharlie Huveneers, Fabrice R A Jaine, Adam Barnett, et al.
Journal of the American Chemical Society|June 26, 2026
A Type II CDK6 Degrader Enables Cellular Targeting beyond the Limits of Type II InhibitionJi Hyeon Kim, Caitlin E Mills, Zuzanna Kozicka, et al.
JACC. Cardiovascular Interventions|February 5, 2018
Neurocognition and Cerebral Lesion Burden in High-Risk Patients Before Undergoing Transcatheter Aortic Valve Replacement: Insights From the SENTINEL TrialRonald M Lazar, Marykathryn A Pavol, Tobias Bormann, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2025
A Bivalent Molecular Glue Linking Lysine Acetyltransferases to Oncogene-induced Cell DeathMeredith N Nix, Sai Gourisankar, Roman C Sarott, et al.
Journal of the American College of Cardiology|November 6, 2016
Protection Against Cerebral Embolism During Transcatheter Aortic Valve ReplacementSamir R Kapadia, Susheel Kodali, Raj Makkar, et al.
Pageof 36

Showing results (341-350 of 359) with videos related to

Sort By:
Pageof 36
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 1, 2026
Impact of multiple sclerosis disease-modifying therapies on chronic lesion tissue expansionDaniel Guilfoyle, Kayla Ward, Samuel Klistorner, et al.
Therapeutic Advances in Neurological Disorders|December 25, 2010
A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosisElliot M Frohman, Gary Cutter, Gina Remington, et al.
Neuroimage. Clinical|May 8, 2024
Thalamic atrophy and dysconnectivity are associated with cognitive impairment in a multi-center, clinical routine, real-word study of people with relapsing-remitting multiple sclerosisRobert Zivadinov, Niels Bergsland, Dejan Jakimovski, et al.
Science (New York, N.Y.)|June 8, 2013
Space partitioning without territoriality in gannetsEwan D Wakefield, Thomas W Bodey, Stuart Bearhop, et al.
Brain : a Journal of Neurology|March 23, 2021
Deep grey matter injury in multiple sclerosis: a NAIMS consensus statementDaniel Ontaneda, Praneeta C Raza, Kedar R Mahajan, et al.
Biological Conservation|September 28, 2021
The power of national acoustic tracking networks to assess the impacts of human activity on marine organisms during the COVID-19 pandemicCharlie Huveneers, Fabrice R A Jaine, Adam Barnett, et al.
Journal of the American Chemical Society|June 26, 2026
A Type II CDK6 Degrader Enables Cellular Targeting beyond the Limits of Type II InhibitionJi Hyeon Kim, Caitlin E Mills, Zuzanna Kozicka, et al.
JACC. Cardiovascular Interventions|February 5, 2018
Neurocognition and Cerebral Lesion Burden in High-Risk Patients Before Undergoing Transcatheter Aortic Valve Replacement: Insights From the SENTINEL TrialRonald M Lazar, Marykathryn A Pavol, Tobias Bormann, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2025
A Bivalent Molecular Glue Linking Lysine Acetyltransferases to Oncogene-induced Cell DeathMeredith N Nix, Sai Gourisankar, Roman C Sarott, et al.
Journal of the American College of Cardiology|November 6, 2016
Protection Against Cerebral Embolism During Transcatheter Aortic Valve ReplacementSamir R Kapadia, Susheel Kodali, Raj Makkar, et al.
Pageof 36